Omnicare Beats Contaminated-Drug FCA Suit

Law360, Washington (August 15, 2012, 1:22 PM EDT) -- A Maryland federal judge dismissed a whistleblower False Claims Act case against Omnicare Inc. on Tuesday that alleged the company violated U.S. Food and Drug Administration regulations by selling contaminated drugs to the government, saying there wasn't enough information to prove fraudulent acts had been committed.

While U.S. District Judge Catherine C. Blake rejected Omnicare's claims that the court doesn't have jurisdiction over former Omnicare employee Barry Rostholder's qui tam case, she noted that Rostholder didn't provide enough information to determine if any fraudulent action had...
To view the full article, register now.